Local-regional approach to diffuse malignant peritoneal mesothelioma.
Sugarbaker
Paul H
PH
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002166:Camptothecin / Q000031:analogs & derivatives / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D010478:Chemotherapy, Cancer, Regional Perfusion; D002945:Cisplatin / Q000627:therapeutic use; D006801:Humans; D006979:Hyperthermia, Induced; D000077146:Irinotecan; D008654:Mesothelioma / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D018365:Neoplasm, Residual; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D000077150:Oxaliplatin; D010534:Peritoneal Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D011355:Prodrugs / Q000627:therapeutic use; D024162:Second-Look Surgery
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D011355:Prodrugs; D000077150:Oxaliplatin; D000077146:Irinotecan; D002945:Cisplatin; D002166:Camptothecin